We are live on
!
Find out more
AA
Alta Advisers Portfolio holdings
AUM
$276M
1-Year Est. Return
26.84%
This Fund
S&P 500
This Quarter
Est. Return
+4.17%
1 Year Est. Return
+26.84%
3 Year Est. Return
+78.95%
5 Year Est. Return
+85.66%
10 Year Est. Return
–
AUM
$130M
AUM Growth
-$13.9M
(-9.6%)
Cap. Flow
-$19M
Cap. Flow
% of AUM
-14.56%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
5
New
1
Increased
–
Reduced
3
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Silicon Motion
SIMO
|
+$107K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
|
+$12.9M |
| 2 |
Vanguard Short-Term Treasury ETF
VGSH
|
+$3.08M |
| 3 |
Vanguard S&P 500 ETF
VOO
|
+$1.7M |
| 4 |
Vanguard FTSE All-World ex-US ETF
VEU
|
+$1.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 0.1% |
| 2 | Healthcare | 0% |
Similar funds
EFP
TLA
MC
RA
IIA
FCT
AWA
RCA
Alta Advisers's Q4 2019 Portfolio in Review
As of Q4 2019, Alta Advisers held 5 positions worth $130M, down 9.6% from $144M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Alta Advisers withdrew a net $19M in Q4 2019, closing 1 position and reducing 3 holdings. Its most notable exit was Reata Pharmaceuticals, Inc. Class A Common Stock, an estimated $12.9M position sold in full.
By sector, the portfolio is most concentrated in Technology at 0.1% of assets, followed by Healthcare.
Against the trend, Alta Advisers opened a new position in Silicon Motion worth $127K.
- Alta Advisers's largest Q4 2019 buy was Silicon Motion: 2,500 shares worth $127K.
- Alta Advisers's biggest Q4 2019 reduction was Vanguard Short-Term Treasury ETF, cutting an estimated $3.08M.
- Alta Advisers fully exited Reata Pharmaceuticals, Inc. Class A Common Stock in Q4 2019, selling an estimated $12.9M.
- Alta Advisers's ten largest holdings make up 100% of its $130M portfolio in Q4 2019.
- Alta Advisers opened 1 new position and closed 1 in Q4 2019.
- Alta Advisers's portfolio value fell 9.6% quarter-over-quarter to $130M.
Based on Alta Advisers's 13F filing for Q4 2019, filed 4 Feb 2020.